Skip to main content
. 2021 Aug 3;40(7):1820–1828. doi: 10.1002/nau.24757

Table 2.

Objective and subjective values at baseline and at follow‐up visits

Baseline 4‐Month visit 12‐Month visit
No. UUI episodes/day, median (IQR) (min‐max) 3.6 (2.2–5.0) 0.0 (0.0–1.7) a 0.0 (0.0–1.7) a
(0.3–9.7) (0.0–7.5) (0.0–6.3)
No. urgency episodes/day, median (IQR) (min‐max) 8.0 (5.2–8.9) 2.7 (0.0–5.0) a 3.3 (1.7–6.0) a
(0.0–12.0) (0–9.3) (0.0–9.0)
No. micturition episodes/day, median (IQR) (min‐max) 9.7 (8.6–11.0) 7.7 (6.3–9.3) a 7.7 (6.4–9.9) a
(8.0–15.7) (4.0–13.0) (4.0–12.5)
Volume voided/micturition (ml), median (IQR) (min‐max) 189 (145–238) 250 (199–326) a 225 (194–297) a
(69–395) (94–458) (102–529)
ICIQ‐UI SF score, median (IQR) (min‐max) 15.4 (13.0–16.9) 4.8 (0.08–11.1) a 5.5 (0.1–8.9) a
(8.3–21.0) (0.0–17.4) (0.0–20.0)
SUI‐VAS score, median (IQR) (min‐max) 6.0 (5.0–8.2) 0.1 (0.0–0.8) a 0.0 (0.0–0.4) a
(0.3–10.0) (0.0–8.7) (0.0–9.7)
UUI‐VAS score, median (IQR) (min‐max) 7.5 (5.0–9.1) 0.5 (0.0–4.0) a 1.6 (0.0–4.7) a
(0.1–10.0) (0.0–9.4) (0.0–10.0)

Abbreviations: ICIQ‐UI SF, International Consultation on Incontinence Questionnaire‐Urinary Incontinence Short Form; IQR, interquartile range; SUI, stress urinary incontinence; UUI, urgency urinary incontinence; VAS, visual analogue scale.

a

All follow‐up values were significantly different from baseline (p < 0.001) as determined by the paired Wilcoxon signed‐rank test with significance level 0.05.